137
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Complexation of cox-2 inhibitors with bovine serum albumin: Interaction mechanism

&
Pages 343-349 | Received 02 Jul 2008, Accepted 21 Nov 2008, Published online: 27 Jul 2009
 

Abstract

Mechanism of interaction of six cox-2 inhibitors – celecoxib, valdecoxib, etoricoxib, parecoxib sodium, meloxicam and nimesulide – with bovine serum albumin (BSA) was studied using fluorescence spectroscopic technique. Results were discussed in terms of the binding parameters, thermodynamics of the binding process, the nature of forces involved in the interaction and the fluorescence quenching mechanism involved. Association constants were of the order of 104–105 for various drugs. Binding affinity varied with the nature of drug. Nature of forces involved in the interaction could be predicted from the thermodynamic parameters for the binding. Meloxicam and nimesulide shared common sites with hydrophobic probe, 1-anilinonaphthalene-8-sulfonate (ANS) on BSA molecule. Stern-Volmer analysis of the quenching data indicated that both tryptophan residues of BSA are fully accessible to the drugs and predominantly static quenching mechanism is involved in the interaction.

Acknowledgement

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.